255 related articles for article (PubMed ID: 34380469)
1. Plasmonic photothermal release of docetaxel by gold nanoparticles incorporated onto halloysite nanotubes with conjugated 2D8-E3 antibodies for selective cancer therapy.
Taheri-Ledari R; Zhang W; Radmanesh M; Cathcart N; Maleki A; Kitaev V
J Nanobiotechnology; 2021 Aug; 19(1):239. PubMed ID: 34380469
[TBL] [Abstract][Full Text] [Related]
2. Fabrication and characterization of polymer-ceramic nanocomposites containing drug loaded modified halloysite nanotubes.
Ghaderi-Ghahfarrokhi M; Haddadi-Asl V; Zargarian SS
J Biomed Mater Res A; 2018 May; 106(5):1276-1287. PubMed ID: 29314595
[TBL] [Abstract][Full Text] [Related]
3. An effective strategy for development of docetaxel encapsulated gold nanoformulations for treatment of prostate cancer.
Thambiraj S; Vijayalakshmi R; Ravi Shankaran D
Sci Rep; 2021 Feb; 11(1):2808. PubMed ID: 33531521
[TBL] [Abstract][Full Text] [Related]
4. pH and near-infrared active; chitosan-coated halloysite nanotubes loaded with curcumin-Au hybrid nanoparticles for cancer drug delivery.
Rao KM; Kumar A; Suneetha M; Han SS
Int J Biol Macromol; 2018 Jun; 112():119-125. PubMed ID: 29378273
[TBL] [Abstract][Full Text] [Related]
5. The tumor-targeting core-shell structured DTX-loaded PLGA@Au nanoparticles for chemo-photothermal therapy and X-ray imaging.
Hao Y; Zhang B; Zheng C; Ji R; Ren X; Guo F; Sun S; Shi J; Zhang H; Zhang Z; Wang L; Zhang Y
J Control Release; 2015 Dec; 220(Pt A):545-555. PubMed ID: 26590021
[TBL] [Abstract][Full Text] [Related]
6. Enhanced docetaxel delivery using sterically stabilized RIPL peptide-conjugated nanostructured lipid carriers: In vitro and in vivo antitumor efficacy against SKOV3 ovarian cancer cells.
Kim CH; Kang TH; Kim BD; Lee TH; Yoon HY; Goo YT; Choi YS; Kang MJ; Choi YW
Int J Pharm; 2020 Jun; 583():119393. PubMed ID: 32376445
[TBL] [Abstract][Full Text] [Related]
7. Halloysite nanotubes in analytical sciences and in drug delivery: A review.
Fizir M; Dramou P; Dahiru NS; Ruya W; Huang T; He H
Mikrochim Acta; 2018 Jul; 185(8):389. PubMed ID: 30046919
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and in vitro/in vivo antitumor efficacy of aptamer-targeted Ecoflex
Ghassami E; Varshosaz J; Jahanian-Najafabadi A; Minaiyan M; Rajabi P; Hayati E
Int J Nanomedicine; 2018; 13():493-504. PubMed ID: 29416331
[TBL] [Abstract][Full Text] [Related]
9. Co-Delivery of Docetaxel and Curcumin via Nanomicelles for Enhancing Anti-Ovarian Cancer Treatment.
Hu Y; Ran M; Wang B; Lin Y; Cheng Y; Zheng S
Int J Nanomedicine; 2020; 15():9703-9715. PubMed ID: 33299312
[TBL] [Abstract][Full Text] [Related]
10. Natural halloysite nanotubes /chitosan based bio-nanocomposite for delivering norfloxacin, an anti-microbial agent in sustained release manner.
Barman M; Mahmood S; Augustine R; Hasan A; Thomas S; Ghosal K
Int J Biol Macromol; 2020 Nov; 162():1849-1861. PubMed ID: 32781129
[TBL] [Abstract][Full Text] [Related]
11. Direct chemical grafted curcumin on halloysite nanotubes as dual-responsive prodrug for pharmacological applications.
Massaro M; Amorati R; Cavallaro G; Guernelli S; Lazzara G; Milioto S; Noto R; Poma P; Riela S
Colloids Surf B Biointerfaces; 2016 Apr; 140():505-513. PubMed ID: 26812638
[TBL] [Abstract][Full Text] [Related]
12. Development of self-assembled nanocarriers to enhance antitumor efficacy of docetaxel trihydrate in MDA-MB-231 cell line.
Rarokar NR; Khedekar PB; Bharne AP; Umekar MJ
Int J Biol Macromol; 2019 Mar; 125():1056-1068. PubMed ID: 30572051
[TBL] [Abstract][Full Text] [Related]
13. Co-delivery of docetaxel and gemcitabine by anacardic acid modified self-assembled albumin nanoparticles for effective breast cancer management.
Kushwah V; Katiyar SS; Dora CP; Kumar Agrawal A; Lamprou DA; Gupta RC; Jain S
Acta Biomater; 2018 Jun; 73():424-436. PubMed ID: 29649635
[TBL] [Abstract][Full Text] [Related]
14. Anti-tumor efficacy of folate modified PLGA-based nanoparticles for the co-delivery of drugs in ovarian cancer.
Li S; Li X; Ding J; Han L; Guo X
Drug Des Devel Ther; 2019; 13():1271-1280. PubMed ID: 31114163
[No Abstract] [Full Text] [Related]
15. Development of chitosan/halloysite/graphitic‑carbon nitride nanovehicle for targeted delivery of quercetin to enhance its limitation in cancer therapy: An in vitro cytotoxicity against MCF-7 cells.
Sabzini M; Pourmadadi M; Yazdian F; Khadiv-Parsi P; Rashedi H
Int J Biol Macromol; 2023 Jan; 226():159-171. PubMed ID: 36435458
[TBL] [Abstract][Full Text] [Related]
16. RIPL peptide-conjugated nanostructured lipid carriers for enhanced intracellular drug delivery to hepsin-expressing cancer cells.
Lee SG; Kim CH; Sung SW; Lee ES; Goh MS; Yoon HY; Kang MJ; Lee S; Choi YW
Int J Nanomedicine; 2018; 13():3263-3278. PubMed ID: 29910614
[TBL] [Abstract][Full Text] [Related]
17. Development and characterization of co-loaded curcumin/triazole-halloysite systems and evaluation of their potential anticancer activity.
Riela S; Massaro M; Colletti CG; Bommarito A; Giordano C; Milioto S; Noto R; Poma P; Lazzara G
Int J Pharm; 2014 Nov; 475(1-2):613-23. PubMed ID: 25223492
[TBL] [Abstract][Full Text] [Related]
18. Multi-Stimuli Nanocomposite Therapeutic: Docetaxel Targeted Delivery and Synergies in Treatment of Human Breast Cancer Tumor.
Taheri-Ledari R; Zhang W; Radmanesh M; Mirmohammadi SS; Maleki A; Cathcart N; Kitaev V
Small; 2020 Oct; 16(41):e2002733. PubMed ID: 32945130
[TBL] [Abstract][Full Text] [Related]
19. Rod in Tube: A Novel Nanoplatform for Highly Effective Chemo-Photothermal Combination Therapy toward Breast Cancer.
Zhang J; Luo X; Wu YP; Wu F; Li YF; He RR; Liu M
ACS Appl Mater Interfaces; 2019 Jan; 11(4):3690-3703. PubMed ID: 30618237
[TBL] [Abstract][Full Text] [Related]
20. Self-Assembled Upconversion Nanoparticle Clusters for NIR-controlled Drug Release and Synergistic Therapy after Conjugation with Gold Nanoparticles.
Cai H; Shen T; Kirillov AM; Zhang Y; Shan C; Li X; Liu W; Tang Y
Inorg Chem; 2017 May; 56(9):5295-5304. PubMed ID: 28402112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
